Search research articles
Contact Us
Filters
Showing results (21-30 of 128) with videos related to
Page
of 13
Sort By:
Biochimica Et Biophysica Acta
|
September 4, 2013
DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac
Friedrich Wartlick, Anita Bopp, Christian Henninger, et al.
Biochimica Et Biophysica Acta
|
May 29, 2004
Inhibition of Rho modulates cytokine-induced prostaglandin E2 formation in renal mesangial cells
Claudia Petry, Gerhard Fritz, Josef Pfeilschifter, et al.
Molecules (Basel, Switzerland)
|
June 10, 2022
Targeting Mechanisms of the DNA Damage Response (DDR) and DNA Repair by Natural Compounds to Improve cAT-Triggered Tumor Cell Death
Jana Aengenvoort, Marlena Sekeres, Peter Proksch, et al.
International Journal of Molecular Medicine
|
November 8, 2005
Lovastatin stimulates p75 TNF receptor (TNFR2) expression in primary human endothelial cells
Tobias Nübel, Steffen Schmitt, Bernd Kaina, et al.
Carcinogenesis
|
February 28, 2004
Ionizing radiation-induced E-selectin gene expression and tumor cell adhesion is inhibited by lovastatin and all-trans retinoic acid
Tobias Nübel, Wolfgang Dippold, Bernd Kaina, et al.
Cell Death Discovery
|
March 22, 2026
Sublethal DNA damage switches off B cell effector programs in an RA-FLS-PBMC co-culture
Denada Bruci, Torsten Lowin, Gerhard Fritz, et al.
DNA Repair
|
November 11, 2018
Werner syndrome (WRN) DNA helicase and base excision repair (BER) factors maintain endothelial homeostasis
Kathrin Laarmann, Joana M Kress, Bernd Kaina, et al.
Stem Cell Research & Therapy
|
June 26, 2026
Endothelial progenitor cell susceptibility to DNA damaging and DDR-modulating compounds determines endothelial differentiation accuracy
Sina Federmann, Michelle Westerhoff, Andreas S Reichert, et al.
Cancer Letters
|
March 23, 2010
Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells
Tamara Cimbora-Zovko, Gerhard Fritz, Nevenka Mikac, et al.
International Journal of Molecular Medicine
|
September 20, 2002
The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide
Renate V Bardeleben, Torsten Dunkern, Bernd Kaina, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 128) with videos related to
Sort By:
Page
of 13
Biochimica Et Biophysica Acta
|
September 4, 2013
DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac
Friedrich Wartlick, Anita Bopp, Christian Henninger, et al.
Biochimica Et Biophysica Acta
|
May 29, 2004
Inhibition of Rho modulates cytokine-induced prostaglandin E2 formation in renal mesangial cells
Claudia Petry, Gerhard Fritz, Josef Pfeilschifter, et al.
Molecules (Basel, Switzerland)
|
June 10, 2022
Targeting Mechanisms of the DNA Damage Response (DDR) and DNA Repair by Natural Compounds to Improve cAT-Triggered Tumor Cell Death
Jana Aengenvoort, Marlena Sekeres, Peter Proksch, et al.
International Journal of Molecular Medicine
|
November 8, 2005
Lovastatin stimulates p75 TNF receptor (TNFR2) expression in primary human endothelial cells
Tobias Nübel, Steffen Schmitt, Bernd Kaina, et al.
Carcinogenesis
|
February 28, 2004
Ionizing radiation-induced E-selectin gene expression and tumor cell adhesion is inhibited by lovastatin and all-trans retinoic acid
Tobias Nübel, Wolfgang Dippold, Bernd Kaina, et al.
Cell Death Discovery
|
March 22, 2026
Sublethal DNA damage switches off B cell effector programs in an RA-FLS-PBMC co-culture
Denada Bruci, Torsten Lowin, Gerhard Fritz, et al.
DNA Repair
|
November 11, 2018
Werner syndrome (WRN) DNA helicase and base excision repair (BER) factors maintain endothelial homeostasis
Kathrin Laarmann, Joana M Kress, Bernd Kaina, et al.
Stem Cell Research & Therapy
|
June 26, 2026
Endothelial progenitor cell susceptibility to DNA damaging and DDR-modulating compounds determines endothelial differentiation accuracy
Sina Federmann, Michelle Westerhoff, Andreas S Reichert, et al.
Cancer Letters
|
March 23, 2010
Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells
Tamara Cimbora-Zovko, Gerhard Fritz, Nevenka Mikac, et al.
International Journal of Molecular Medicine
|
September 20, 2002
The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide
Renate V Bardeleben, Torsten Dunkern, Bernd Kaina, et al.
Page
of 13